240 related articles for article (PubMed ID: 35778272)
1. Possible future avenues for myositis therapeutics: DM, IMNM and IBM.
Connolly CM; Plomp L; Paik JJ; Allenbach Y
Best Pract Res Clin Rheumatol; 2022 Jun; 36(2):101762. PubMed ID: 35778272
[TBL] [Abstract][Full Text] [Related]
2. Pathophysiological Mechanisms and Treatment of Dermatomyositis and Immune Mediated Necrotizing Myopathies: A Focused Review.
Kamperman RG; van der Kooi AJ; de Visser M; Aronica E; Raaphorst J
Int J Mol Sci; 2022 Apr; 23(8):. PubMed ID: 35457124
[TBL] [Abstract][Full Text] [Related]
3. [Idiopathic inflammatory myopathies. A review].
Acosta I; Matamala JM; Jara P; Pino F; Gallardo A; Verdugo R
Rev Med Chil; 2019 Mar; 147(3):342-355. PubMed ID: 31344172
[TBL] [Abstract][Full Text] [Related]
4. Classification of idiopathic inflammatory myopathies: pathology perspectives.
Tanboon J; Nishino I
Curr Opin Neurol; 2019 Oct; 32(5):704-714. PubMed ID: 31369423
[TBL] [Abstract][Full Text] [Related]
5. Identification of Unique microRNA Profiles in Different Types of Idiopathic Inflammatory Myopathy.
Muñoz-Braceras S; Pinal-Fernandez I; Casal-Dominguez M; Pak K; Milisenda JC; Lu S; Gadina M; Naz F; Gutierrez-Cruz G; Dell'Orso S; Torres-Ruiz J; Grau-Junyent JM; Selva-O'Callaghan A; Paik JJ; Albayda J; Christopher-Stine L; Lloyd TE; Corse AM; Mammen AL
Cells; 2023 Sep; 12(17):. PubMed ID: 37681930
[TBL] [Abstract][Full Text] [Related]
6. Paraneoplastic myopathies.
Mammen AL
Handb Clin Neurol; 2024; 200():327-332. PubMed ID: 38494286
[TBL] [Abstract][Full Text] [Related]
7. Radiographic patterns of muscle involvement in the idiopathic inflammatory myopathies.
Day JA; Bajic N; Gentili S; Patel S; Limaye V
Muscle Nerve; 2019 Nov; 60(5):549-557. PubMed ID: 31397909
[TBL] [Abstract][Full Text] [Related]
8. Inclusion body myositis.
Dimachkie MM; Barohn RJ
Neurol Clin; 2014 Aug; 32(3):629-46, vii. PubMed ID: 25037082
[TBL] [Abstract][Full Text] [Related]
9. Intravenous Immunoglobulin in Idiopathic Inflammatory Myopathies: a Practical Guide for Clinical Use.
Gandiga PC; Ghetie D; Anderson E; Aggrawal R
Curr Rheumatol Rep; 2023 Aug; 25(8):152-168. PubMed ID: 37261663
[TBL] [Abstract][Full Text] [Related]
10. Inflammatory muscle disease - An update.
Baig S; Paik JJ
Best Pract Res Clin Rheumatol; 2020 Feb; 34(1):101484. PubMed ID: 32046904
[TBL] [Abstract][Full Text] [Related]
11. Contribution of Complement, Microangiopathy and Inflammation in Idiopathic Inflammatory Myopathies.
Honda M; Shimizu F; Sato R; Nakamori M
J Neuromuscul Dis; 2024; 11(1):5-16. PubMed ID: 38143369
[TBL] [Abstract][Full Text] [Related]
12. What is New in Idiopathic Inflammatory Myopathies: Mechanisms and Therapies.
Khadilkar SV; Dhamne MC
Ann Indian Acad Neurol; 2020; 23(4):458-467. PubMed ID: 33223661
[TBL] [Abstract][Full Text] [Related]
13. Dipeptidyl peptidase 4/CD26 expression in human idiopathic inflammatory myopathies reveals skeletal muscle injury and vascular inflammation.
De Lorenzo R; Monno A; Sciorati C; Lorenzetti I; Cavalli S; Bonomi F; Previtali SC; Rovere-Querini P
Clin Exp Rheumatol; 2022 Feb; 40(2):237-246. PubMed ID: 34796850
[TBL] [Abstract][Full Text] [Related]
14. Where are we moving in the classification of idiopathic inflammatory myopathies?
Tanboon J; Uruha A; Stenzel W; Nishino I
Curr Opin Neurol; 2020 Oct; 33(5):590-603. PubMed ID: 32852298
[TBL] [Abstract][Full Text] [Related]
15. Myostatin in idiopathic inflammatory myopathies: Serum assessment and disease activity.
Mahoudeau A; Anquetil C; Tawara N; Khademian H; Amelin D; Bolko L; Silvestro M; Cin JD; Tendrel B; Tardif V; Mariampillai K; Butler-Browne G; Benveniste O; Allenbach Y
Neuropathol Appl Neurobiol; 2023 Feb; 49(1):e12849. PubMed ID: 36168256
[TBL] [Abstract][Full Text] [Related]
16. Clinical utility of anti-cytosolic 5'-nucleotidase 1A antibody in idiopathic inflammatory myopathies.
Ikenaga C; Findlay AR; Goyal NA; Robinson S; Cauchi J; Hussain Y; Wang LH; Kershen JC; Beson BA; Wallendorf M; Bucelli RC; Mozaffar T; Pestronk A; Weihl CC
Ann Clin Transl Neurol; 2021 Mar; 8(3):571-578. PubMed ID: 33556224
[TBL] [Abstract][Full Text] [Related]
17. Transcriptomic profiling reveals distinct subsets of immune checkpoint inhibitor induced myositis.
Pinal-Fernandez I; Quintana A; Milisenda JC; Casal-Dominguez M; Muñoz-Braceras S; Derfoul A; Torres-Ruiz J; Pak K; Dell'Orso S; Naz F; Gutierrez-Cruz G; Milone M; Shelly S; Duque-Jaimez Y; Tobias-Baraja E; Matas-Garcia A; Garrabou G; Padrosa J; Ros J; Trallero-Araguás E; Walitt B; Christopher-Stine L; Lloyd TE; Zhao C; Swift S; Rajan A; Grau-Junyent JM; Selva-O'Callaghan A; Liewluck T; Mammen AL
Ann Rheum Dis; 2023 Jun; 82(6):829-836. PubMed ID: 36801811
[TBL] [Abstract][Full Text] [Related]
18. Immune-Mediated Necrotizing Myopathy: Update on Diagnosis and Management.
Basharat P; Christopher-Stine L
Curr Rheumatol Rep; 2015 Dec; 17(12):72. PubMed ID: 26515574
[TBL] [Abstract][Full Text] [Related]
19. Perivascular and endomysial macrophages expressing VEGF and CXCL12 promote angiogenesis in anti-HMGCR immune-mediated necrotizing myopathy.
Lia A; Annese T; Fornaro M; Giannini M; D'Abbicco D; Errede M; Lorusso L; Amati A; Tampoia M; Trojano M; Virgintino D; Ribatti D; Serlenga L; Iannone F; Girolamo F
Rheumatology (Oxford); 2022 Aug; 61(8):3448-3460. PubMed ID: 34864921
[TBL] [Abstract][Full Text] [Related]
20. The interferon in idiopathic inflammatory myopathies: Different signatures and new therapeutic perspectives. A literature review.
Gasparotto M; Franco C; Zanatta E; Ghirardello A; Zen M; Iaccarino L; Fabris B; Doria A; Gatto M
Autoimmun Rev; 2023 Jun; 22(6):103334. PubMed ID: 37068699
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
